116 related articles for article (PubMed ID: 36367178)
1. Expression of Concern: FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36367178
[No Abstract] [Full Text] [Related]
2. FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.
Xin YL; Yu JZ; Yang XW; Liu CY; Li YH; Feng L; Chai Z; Yang WF; Wang Q; Jiang WJ; Zhang GX; Xiao BG; Ma CG
Biosci Rep; 2015 Jul; 35(5):. PubMed ID: 26223433
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of Rho kinase inhibitor FSD-C10 in a mouse model of Alzheimer's disease.
Gu QF; Yu JZ; Wu H; Li YH; Liu CY; Feng L; Zhang GX; Xiao BG; Ma CG
Exp Ther Med; 2018 Nov; 16(5):3929-3938. PubMed ID: 30344671
[TBL] [Abstract][Full Text] [Related]
5. FSD-C10 Shows Therapeutic Effects in Suppressing oxidized low-density lipoprotein (ox-LDL)-Induced Human Brain Microvascular Endothelial Cells Apoptosis via Rho-Associated Coiled-Coil Kinase (ROCK)/Mitogen-Activated Protein Kinase (MAPK) Signaling.
Wang X; Mao R; Chen W
Med Sci Monit; 2018 Aug; 24():5509-5516. PubMed ID: 30088495
[TBL] [Abstract][Full Text] [Related]
6. FSD-C10, a Fasudil derivative, promotes neuroregeneration through indirect and direct mechanisms.
Li YH; Xie C; Zhang Y; Li X; Zhang HF; Wang Q; Chai Z; Xiao BG; Thome R; Zhang GX; Ma CG
Sci Rep; 2017 Jan; 7():41227. PubMed ID: 28112256
[TBL] [Abstract][Full Text] [Related]
7. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
[TBL] [Abstract][Full Text] [Related]
8. The Rho/Rho-associated protein kinase inhibitor fasudil in the protection of endothelial cells against advanced glycation end products through the nuclear factor κB pathway.
Lu Y; Li H; Jian W; Zhuang J; Wang K; Peng W; Xu Y
Exp Ther Med; 2013 Aug; 6(2):310-316. PubMed ID: 24137180
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms.
Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG
Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558
[TBL] [Abstract][Full Text] [Related]
10. Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway.
Gu Y; Feng Y; Yu J; Yuan H; Yin Y; Ding J; Zhao J; Xu Y; Xu J; Che H
Oncotarget; 2017 Nov; 8(61):104104-104112. PubMed ID: 29262624
[TBL] [Abstract][Full Text] [Related]
11. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
12. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
13. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
14. [Effects of fasudil on the expression of Rho kinase-1 and airway inflammation in a mouse model of asthma.].
Wu FQ; Zhu SY; He CX; Gu MX
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Nov; 32(11):847-9. PubMed ID: 20079297
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
16. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
17. Fasudil on Myocardial Injury in Rats with Myocardial Ischemia and Reperfusion through Rho-ROCK Signal Pathway.
Zhu Z; Qiu B; Wang Q; Wei W; Huang J; Duan W
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):64-72. PubMed ID: 35818270
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Zhang L; Li Q; Liu Z; Liu W; Zhao M
Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
20. Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway.
Liu FT; Yang YJ; Wu JJ; Li S; Tang YL; Zhao J; Liu ZY; Xiao BG; Zuo J; Liu W; Wang J
Brain Res; 2016 Feb; 1632():9-18. PubMed ID: 26683082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
